Patents by Inventor Michael J. Thirman

Michael J. Thirman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutics to inhibit MLL-menin interaction for treating leukemia
    Patent number: 8557778
    Abstract: Cell permeable peptides derived from MLL that block the interaction of MLL with menin for the treatment of acute myeloid and acute lymphoid leukemia are disclosed. Small molecules interfere with the interaction of MLL with any of its binding partners.
    Type: Grant
    Filed: July 18, 2012
    Date of Patent: October 15, 2013
    Assignee: The University of Chicago
    Inventor: Michael J. Thirman
  • THERAPEUTICS TO INHIBIT MLL-MENIN INTERACTION FOR TREATING LEUKEMIA
    Publication number: 20120322742
    Abstract: Cell permeable peptides derived from MLL that block the interaction of MLL with menin for the treatment of acute myeloid and acute lymphoid leukemia are disclosed. Small molecules interfere with the interaction of MLL with any of its binding partners.
    Type: Application
    Filed: July 18, 2012
    Publication date: December 20, 2012
    Applicant: THE UNIVERSITY OF CHICAGO
    Inventor: Michael J. Thirman
  • Therapeutics to inhibit MLL-menin interaction for treating leukemia
    Patent number: 8242078
    Abstract: Cell permeable peptides derived from MLL that block the interaction of MLL with menin for the treatment of acute myeloid and acute lymphoid leukemia are disclosed. Small molecules interfere with the interaction of MLL with any of its binding partners.
    Type: Grant
    Filed: October 19, 2007
    Date of Patent: August 14, 2012
    Assignee: The University of Chicago
    Inventor: Michael J. Thirman
  • THERAPEUTICS TO INHIBIT MLL-MENIN INTERACTION FOR TREATING LEUKEMIA
    Publication number: 20090298772
    Abstract: Cell permeable peptides derived from MLL that block the interaction of MLL with menin for the treatment of acute mycloid and acute lymphoid leukemia are disclosed. Small molecules interfere with the interaction of MLL with any of its binding partners.
    Type: Application
    Filed: October 19, 2007
    Publication date: December 3, 2009
    Applicant: THE UNIVERSITY OF CHICAGO
    Inventor: Michael J. Thirman